1. CF Pharma Ltd. H-1097 Budapest, Kén u. 5. Hungary
CF
CF CF Phone: (+36-1)-280-3951, Fax : (36-1)-280-6272
e-mail:cfpharma@cfpharma.hu, web site:www.cfpharma.hu
List of Patents
API N u m b e r of the p a t e n t
 Lamotrigine I. WO 03008393; EP 1311492; US 6683182
 Lamotrigine II. HU 0103073
 Bicalutamide I. WO 03097590, EP 1506170, US 2005/0033082
 Bicalutamide II. EP 1669347;
 Ropinirole EP 1568689; US 2005/0192338
 Topiramate EP 1627881; US 2006/0040874
 Tazobactam EP 1686131, US 2006/0173177
 Lercanidipine EP 1860102
 Pramipexol EP 1878731
 Bosentan under development
 Entecavir under development
 Pemetrexed under development
 Prucalopride under development
 Tilorone under development
List of know-hows
The following 16 processes for manufacturing APIs were kept as know-hows:
Apomorphine Cabergoline Pentosan Polysulfate Sodium (PPS)
Aripiprazol Exemestane for vet. use
Atracurium besylate Methotrexate Perindopril
(R) –Bicalutamide Mirtazapine Physostigmine
Biperidene Pentosan Polysulfate Sodium (PPS) for Tianeptine besylate
Cisatracurium human use Torsemide